| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |